Guillermo M Ruiz-Palacios
Biographic Data
| ID | 5466592 |
|---|---|
| NAME | Guillermo M Ruiz-Palacios |
| GIVEN NAMES | Guillermo M |
| FAMILY NAME | Ruiz-Palacios |
| SIGNATURE | RUIZ-PALACIOS G M |
| AFFILIATIONS | From the National Institute of Allergy and Infectious Diseases, National Institutes of Health (J.H.B., K.M.T., L.E.D., S.N., H.C.L.), and the Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences (T.H.B.), Bethesda, the Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick (T. Bonnett), and Emmes, Rockville (M.G., M.M.) — all in Maryland; Emory University, Atlanta (A.K.M.); Montefiore Medical... |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 1 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
International clinical research networks – a collaborative approach for pandemic preparedness and response
In the last 100 years, the world has experienced four influenza pandemics, with an occurrence every 15-30 years resulting in an annual probability of 3% to 7% [1]. More recently, other pathogens including SARS, MERS, and the recent SARS CoV-2, have stressed the need to improve pandemic preparedness and response capabilities. Developing strategies to promote [...]
Remdesivir for the Treatment of Covid-19 — Final Report
BACKGROUND: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. METHODS: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection. Patients were randomly assigned to receive either remdesivir (2…
Protecting Infants Through Human Milk
No prominent works on this page.
Protecting Infants Through Human Milk
Remdesivir for the Treatment of Covid-19 — Final Report
BACKGROUND: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. METHODS: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection. Patients were randomly assigned to receive either remdesivir (2…
International clinical research networks – a collaborative approach for pandemic preparedness and response
In the last 100 years, the world has experienced four influenza pandemics, with an occurrence every 15-30 years resulting in an annual probability of 3% to 7% [1]. More recently, other pathogens including SARS, MERS, and the recent SARS CoV-2, have stressed the need to improve pandemic preparedness and response capabilities. Developing strategies to promote [...]
Medicine (3 works) · 2019-20 coronavirus outbreak (2 works) · COVID-19 Clinical Research Studies (2 works) · Outbreak (2 works) · Breastfeeding (1 work) · Breastfeeding (1 work) · Breastfeeding Practices and Influences (1 work) · Business (1 work) · Child Nutrition and Water Access (1 work) · Coronavirus disease 2019 (COVID-19) (1 work)